NCT05847972

Brief Summary

Limitation of ankle dorsiflexion is directly related to pronated foot. For its treatment, plantar orthoses and manual therapy are used. There is a lack of evidence on their combination, as to when the cast should be taken after manipulation. Our hypothesis proposes that it is more effective to cast immediately after manipulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
29 days until next milestone

Study Start

First participant enrolled

June 6, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2023

Completed
Last Updated

January 17, 2024

Status Verified

January 1, 2024

Enrollment Period

6 months

First QC Date

April 5, 2023

Last Update Submit

January 15, 2024

Conditions

Keywords

ankleplantar orthoses

Outcome Measures

Primary Outcomes (1)

  • Change from baseline dynamic degrees of ankle dorsiflexion at 12 weeks

    Measured with Kinovea software. The patient will be recorded running in slow motion and the peroneal malleolus, the centre of the heel by the lateral edge and the head of the V metatarsal will be marked. It will then be analysed using Kinovea software

    At baseline; post 1 (inmmediate); post 2 (3weeks); post 3 (6weeks) and post 4 (12weeks)

Secondary Outcomes (3)

  • Degrees of DF of the ankle in closed kinetic chain with the Lunge Test using LegMotion

    At baseline; post 1 (inmmediate); post 2 (3weeks); post 3 (6weeks) and post 4 (12weeks)

  • Degrees of pronation in dynamics, measured with Runscribe (DP)

    At baseline; post 1 (inmmediate); post 2 (3weeks); post 3 (6weeks) and post 4 (12weeks)

  • Foot Function Index

    At baseline; post 1 (inmmediate); post 2 (3weeks); post 3 (6weeks) and post 4 (12weeks)

Study Arms (2)

Experimental Group

EXPERIMENTAL

A will undergo MWM and have their moulds taken in phenolic foam immediately after the musculoskeletal manipulation.

Procedure: MWM (Mobilization with movement)Device: Plantar orthoses

Control Group

PLACEBO COMPARATOR

Participants will undergo MWM and moulds will be taken one week after the musculoskeletal manipulation.

Procedure: MWM (Mobilization with movement)Device: Plantar orthoses

Interventions

This manipulation is intended to improve ankle dorsiflexion. One session of 3 sets of 20 slow ankle dorsiflexion's separated by 10 seconds of rest will be performed.

Control GroupExperimental Group

Procedure: MWM All participants will undergo MWM. This manipulation is intended to improve ankle dorsiflexion. One session of 3 sets of 20 slow ankle dorsiflexion's separated by 10 seconds of rest will be performed. Procedure: Plantar orthoses The moulds will be taken immediately after the manipulation. The PO will be made of resin (0.8mm +1.2mm), 2mm hard EVA heel stabiliser, 3mm semi-hard EVA cover. The PO should be worn for 3 months to obtain the results of the study.

Control GroupExperimental Group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Runners who run on asphalt.
  • Individuals who run at least \>6 hours per week for 6 months prior to study participation.
  • Participants with hyperpronated feet secondary to ankle ROM limitation.
  • Runners with an ankle DF difference of \>1.5cm in both feet or an ankle DF of less than 11.5cm according to the Lunge Test.

You may not qualify if:

  • Individuals who have suffered a major injury in the previous two months.
  • FPI less than 6.
  • Runners wearing minimalist footwear into which PO cannot be inserted.
  • Individuals already undergoing treatment with plantar supports.
  • Chronic widespread pain, including fibromyalgia.
  • Systemic rheumatic pathologies.
  • History of recent trauma or surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Juan Vicente-Mampel

Torrent, Valencia, 46900, Spain

Location

MeSH Terms

Conditions

Ankle InjuriesDisease

Interventions

Movement

Condition Hierarchy (Ancestors)

Leg InjuriesWounds and InjuriesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physiological PhenomenaMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The groups will be arranged randomly and the masking technique to be used will the single blind procedure. The random allocation to each group will be made just by the software Epidat version 4.2 of the Galician Health Service (link: https://www.sergas.es/Saude-publica/EPIDAT?idioma=es).
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2023

First Posted

May 8, 2023

Study Start

June 6, 2023

Primary Completion

December 11, 2023

Study Completion

December 11, 2023

Last Updated

January 17, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations